Eukaryotic Translation Initiation Factor 2B, Subunit 1 Alpha, 26kDa (EIF2B1) Peptide
EIF2B1
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all EIF2B1 products
- EIF2B1 (Eukaryotic Translation Initiation Factor 2B, Subunit 1 Alpha, 26kDa (EIF2B1))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-EIF2B1 antibody (Catalog #: ARP51963_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- EIF2B1 (Eukaryotic Translation Initiation Factor 2B, Subunit 1 Alpha, 26kDa (EIF2B1))
- Background
-
EIF2B1 belongs to the EIF-2B alpha/beta/delta subunits family. It catalyzes the exchange of eukaryotic initiation factor 2-bound GDP for GTP. Defects in EIF2B1 are a cause of leukoencephalopathy with vanishing white matter (VWM).
Alias Symbols: EIF-2B, EIF-2Balpha, EIF2B, EIF2BA, MGC117409, MGC125868, MGC125869
Protein Interaction Partner: ADRB2,ADRA2A,ADRA2B,ADRA2C,ADRB2,ARL4D,CREBBP,EIF2B1,EIF2B2,EIF2S1,EIF2S2,MRPL4,ADRA2B,ADRA2C,ADRB2,ARHGDIA,ARL4D,DCD,EIF2B3,EIF2B5,EIF2S1,HNRNPL,MRPL4,PDIA4
Protein Size: 305 - Molecular Weight
- 34 kDa
- Gene ID
- 1967
- NCBI Accession
- NM_001414, NP_001405
- UniProt
- Q14232
-
You are here:
